Beyond the NDA:
- Discover how Real World Evidence studies extend their influence beyond NDA dossiers.
- Explore how these studies play a crucial role in Health Technology Assessment (HTA) preparation, providing invaluable insights for market access and reimbursement strategies. Implementation Strategies: Get an exclusive look at the real-world approaches that companies are adopting to implement RWE studies effectively.
- Learn from industry experts, Laura Fabbri, PhD, and Sreeram Ramagopalan, PhD, MBA about the practical aspects of integrating RWE into drug development pipelines and decision-making processes.
Whether you’re a seasoned pharmaceutical professional, a regulatory expert, or a healthcare stakeholder, this webinar will equip you with the knowledge and insights needed to navigate the evolving landscape of Real World Evidence and its impact on modern healthcare.
